Frequent expression of interleukin-10 by Epstein-Barr virus-harboring tumor cells of Hodgkin's disease

Blood

Volumn 87, Issue 7, 1996, Pages 2918-2929

  Herbst, Hermann ^a   Foss, Hans Dieter ^b   Samol, Jens ^b   Araujo, Iguaracyra ^b   Klotzbach, Heike ^b   Krause, Hans ^b   Agathanggelou, Angelo ^b   Niedobitek, Gerald ^b   Stein, Harald ^b  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; INTERLEUKIN 10; INTERLEUKIN 4; RNA; VIRUS PROTEIN; VIRUS RNA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CONTROLLED STUDY; EPSTEIN BARR VIRUS; GENE EXPRESSION; HODGKIN DISEASE; HUMAN; HUMAN CELL; HUMAN TISSUE; IN SITU HYBRIDIZATION; INFECTIOUS MONONUCLEOSIS; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; REED STERNBERG CELL; TUMOR CELL LINE; VIRUS GENE;

EID: 0029986054     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v87.7.2918.bloodjournal8772918     Document Type: Article

References (63)

1. Herbst H, Dallenbach F, Hummel M, Niedobitek G, Pileri S, Müller-Lantzsch N, Stein H: Epstein-Barr virus latent membrane antigen expression in Hodgkin and Reed-Sternberg cells. Proc Natl Acad Sci USA 88:4766, 1991
2. Pallesen G, Hamilton-Dutoit SJ, Rowe M, Young LS: Expression of Epstein-Barr virus latent gene products in tumour cells of Hodgkin's disease. Lancet 337:320, 1991
3. Herbst H, Niedobitek G: Epstein-Barr virus in Hodgkin's disease. EBV Report 1:31, 1994
4. Herbst H, Steinbrecher E, Niedobitek G, Young LS, Brooks L, Müller-Lantzsch N, Stein H: Distribution and phenotype of Epstein-Barr virus-harboring cells in Hodgkin's disease. Blood 80:484, 1992
5. Thorley-Lawson DA, Israelsohn ES: Generation of specific cytotoxic T cells with a fragment of the Epstein-Barr virus-encoded p63/latent membrane protein. Proc Natl Acad Sci USA 84:5384, 1987
6. Murray RJ, Wang D, Young LS, Wang F, Rowe M, Kieff E, Rickinson AB: Epstein-Barr virus-specific cytotoxic T-cell recognition of transfectants expressing the virus-encoded latent membrane protein LMP. J Virol 62:3747, 1988
7. Murray RJ, Kurilla MG, Griffin HM, Brooks JM, Mackett M, Arrand JR, Rowe M, Burrows SR, Moss DJ, Kieff E, Rickinson AB: Human cytotoxic T-cell responses against Epstein-Barr virus nuclear antigens demonstrated by using recombinant vaccinia virus. Proc Natl Acad Sci USA 87:2906, 1990
8. Miyashita EM, Yang B, Lam KM, Crawford DH, Thorley-Lawson DA: A novel form of Epstein-Barr virus latency in normal B cells in vivo. Cell 80:593, 1995
9. Rowe M, Rowe DT, Gregory CD, Young LS, Farrell PJ, Rupani H, Rickinson AB: Differences in B cell growth phenotype reflect novel patterns of Epstein-Barr virus latent gene expression in Burkitt's lymphoma cells. EMBO J 6:2743, 1987
10. Hamilton-Dutoit SJ, Rea D, Raphael M, Sandvej K, Delecluse HJ, Gisselbrecht C, Marelle L, van Krieken HJ, Pallesen G: Epstein-Barr virus latent gene expression and tumor cell phenotype in acquired immunodeficiency syndrome-related non-Hodgkin's lymphoma. Correlation of lymphoma phenotype with three distinct patterns of viral latency. Am J Pathol 143:1072, 1993
11. Mosmann TR: Properties and functions of interleukin-10. Adv Immunol 56:1, 1994
12. Miyazaki I, Cheung KK, Dosch HM: The role of the IL-10 and other EBV latency genes early during B cell growth transformation. Semin Virol 5:405-414, 1994
13. Vieira P, De Waal-Malefyt R, Dang MN, Johnson KE, Kastelein R, Fiorentino DF, de Vries JE, Roncarolo MG, Mosmann TR, Moore KW: Isolation and expression of human cytokine synthesis inhibitory factor cDNA clones: Homology to Epstein Barr virus open reading frame BCRFI. Proc Natl Acad Sci USA 88:1172, 1991
14. De Waal-Malefyt R, Abrams J, Bennett B, Figdor CG, de Vries JE: Interleukin-10 (IL-10) inhibits cytokine synthesis by human monocytes: An autoregulatory role of IL-10 produced by monocytes. J Exp Med 174:1209, 1991
15. Fiorentino DF, Zlotnik A, Vieira P, Mosmann TR, Howard M, Moore KW, O'Garra A: IL-10 acts on the antigen presenting cell to inhibit cytokine production by Th1 cells. J Immunol 146:3444, 1991
16. Taga K, Mostowski H, Tosato G: Human interleukin-10 can directly inhibit T cell growth. Blood 81:2964, 1993
17. De Waal-Malefyt R, Haanen J, Spits H, Roncarolo MG, te Velde A, Figdor C, Johnson K, Kastelein R, Yssel H, de Vries JE: Interleukin-10 (IL-10) and viral IL-10 strongly reduce antigen specific human T cell proliferation by diminishing the antigen presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression. J Exp Med 174:915, 1991
18. Thompson-Snipes LA, Dhar V, Bond MW, Mosmann TR, Moore KW, Rennick DM: Interleukin 10: A novel stimulatory factor for mast cells and their progenitors. J Exp Med 173:507, 1991
19. Rousset F, Garcia E, Defrance T, Peronne C, Vezzio N, Hsu DH, Kastelein R, Moore KW, Banchereau J: Interleukin-10 is a potent growth and differentiation factor for activated human B lymphocytes. Proc Natl Acad Sci USA 89:1890, 1992
20. Ryon JJ, Hayward SD, MacMahon EME, Mann RB, Ling Y, Charache P, Andersen Phelan J, Miller G, Ambinder RF: In situ detection of lytic Epstein-Barr virus infection: Expression of the NotI early gene and viral interleukin-10 late gene in clinical specimens. J Infect Dis 168:345, 1993
21. Burdin N, Peronne C, Banchereau J, Rousset F: Epstein Barr virus transformation induces B lymphocytes to produce human interleukin 10. J Exp Med 177:295, 1993
22. Benjamin D, Knobloch TJ, Dayton MA: Human B cell interleukin-10: B cell lines derived from patients with acquired immunodeficiency syndrome and Burkitt's lymphoma constitutively secrete large quantities of interleukin-10. Blood 80:1289, 1992
23. Emilie D, Touitou R, Raphael M, Peuchmaur M, Devergnee O, Rea D, Coumbraras J, Crevon MC, Edelman L, Joab I, Galanaud P: In vivo production of interleukin-10 by malignant cells in AIDS lymphomas. Eur J Immunol 22:2937, 1992
24. Paul WE: Interleukin-4: A prototypic immunoregulatory lymphokine. Blood 77:1859, 1991
25. Sieling PA, Abrams JS, Yamamura M, Salgame P, Bloom BR, Rea TH, Modlin RL: Immunosuppressive roles for IL-10 and IL-4 in human infection. In vitro modulation of T cell responses in leprosy. J Immunol 150:5501, 1993
26. Sher A, Gazzinelli RT, Oswald IP, Clerici M, Kullberg M, Pearce EJ, Berzofsky JA, Mosmann TR, James SL, Morse HC: Role of T cell derived cytokines in the downregulation of immune responses in parasitic and retroviral infection. Immunol Rev 127:183, 1992
27. Foss HD, Herbst H, Hummel M, Araujo I, Latza U, Ranscò C, Dallenbach F, Stein H: Patterns of cytokine gene expression in infectious mononucleosis. Blood 83:707, 1994
28. Diehl V, Kirchner HH, Burrichter H, Stein H, Fonatsch C, Gerdes J, Schaadt M, Heit W, Uchanska-Ziegler B, Heintz F, Sueno K: Characteristics of Hodgkin's disease-derived cell lines. Cancer Treat Rep 66:615, 1982
29. Jones DB, Furley AJW, Gerdes J, Greaves MF, Stein H, Wright DH: Phenotypic and genotypic analyses of two cell lines derived from Hodgkin's disease tissue biopsies. Recent Results Cancer Res 117:62, 1988
30. Kamesaki H, Fukuhara S, Tatsumi E, Uchino H, Yamabe H, Miwa H, Shirakawa S, Halanaka M, Honjo T: Cytochemical, immunologie, chromosomal and molecular genetic analysis of a novel cell line derived from Hodgkin's disease. Blood 68:285, 1986
31. Stein H, Gatter K, Asbahr H, Mason DY. Use of freeze-dried paraffin-embedded sections for immunohistologic staining with monoclonal antibodies. Lab Invest 52:676, 1985
32. Yokota T, Otsuka T, Mosmann T, Banchereau J, DeFrance T, Blanchard D, De Vries JE, Lee F, Arai K: Isolation and characterization of a human interleukin cDNA clone, homologous to mouse B-cell stimulatory factor 1, that expresses B-cell- and T-cell-stimulating activities. Proc Natl Acad Sci USA 83:5894, 1986
33. Sutherland GR, Baker E, Callen DF, Hyland VJ, Wong G, Clark S, Jones SS, Eglinton LK, Shannon MF, Lopez AF: Interleukin-4 is at 5q31 and interleukin-6 is at 7p15. Hum Genet 79:335, 1988
34. Milani S, Herbst H, Schuppan D, Hahn EG, Stein H: In situ hybridization for procollagen types I, III, and IV mRNA in normal and fibrotic rat liver: Evidence for predominant expression in non-parenchymal liver cells. Hepatology 10:84, 1989
35. Williamson DJ: Specificity of riboprobes for intracellular RNA in hybridization histochemistry. J Histochem Cytochem 26:811, 1988
36. Kunzendorf U, Krüger-Krasagakes S, Notter M, Hock H, Walz G, Diamantstein T: A sialyl-Le(x)-negative melanoma cell line binds to E-selectin but not to P-selectin. Cancer Res 54:1109, 1994
37. Krüger-Krasagakes S, Krasagakis K, Garbe C, Schmitt E, Hills C, Blankenstein T, Diamantstein T: Expression of interleukin-10 in human melanomas. Br J Cancer 70:1182, 1994
38. Jücker M, Abts H, Li W, Schindlet R, Merz H, Günther A, von Kalle C, Schaadt M, Diamantstein T, Feller AC, Krueger GRF, Diehl V, Blankenstein T, Tesch H: Expression of interleukin-6 and interleukin-6 receptor in Hodgkin's disease. Blood 77:2413, 1991
39. Foss HD, Herbst H, Oelmann E, Samol J, Grebe M, Blankenstein T, Matthes J, Qin ZH, Falini B, Pileri S, Diamantstein T, Stein H: Lymphotoxin, tumor necrosis factor and interleukin-6 gene transcripts are present in Hodgkin and Reed-Sternberg cells of most Hodgkin's disease cases. Br J Haematol 84:627, 1993
40. Butch AW, Chung GH, Hoffmann JW, Nahm MH: Cytokine expression by germinal center cells. J Immunol 150:39, 1993
41. Newcom SR, Ansari AA, Gu L: Interleukin-4 is an autocrine growth factor secreted by the L-428 Reed-Sternberg cell. Blood 79:191, 1992
42. Kretschmer C, Jones DB, Morrison K, Schlueter C, Feist W, Ulmer AJ, Arnoldi J, Matthes J, Diamantstein T, Flad HJ, Gerdes J: Tumor necrosis factor-α and lymphotoxin production in Hodgkin's disease. Am J Pathol 137:341, 1990
43. Merz H, Houssiau FA, Orscheschek K, Renauld JC, Fliedner A, Herin M, Noel H, Kadin M, Müller-Hermelink HK, Van Snick J, Feller AC: Interleukin-9 expression in human malignant lymphomas: Unique association with Hodgkin's disease and large cell anaplastic lymphoma. Blood 78:1311, 1991
44. Xerri L, Birg F, Guigou V, Bouabdallah R, Poizot-Martin I, Hassoun J: In situ expression of the IL-1α and the TNF-α genes by Reed-Sternberg cells in Hodgkin's disease. Int J Cancer 50:689, 1992
45. Foss HD, Hummel M, Gottstein S, Ziemann K, Falini B, Herbst H, Stein H: Frequent expression of IL-7 gene transcripts in tumor cells of classical Hodgkin's disease. Am J Pathol 146:1, 1995
46. Samoszuk M, Nansen L: Detection of interleukin-5 messenger RNA in Reed-Sternberg cells of Hodgkin's disease with eosinophilia. Blood 75:13, 1990
47. Grass HJ, Brach MA, Drexler HG, Bonifer R, Mertelsmann RH, Herrmann F: Expression of cytokine genes, cytokine receptor genes, and transcription factors in cultured Hodgkin and Reed-Stemberg cells. Cancer Res 52:3353, 1992
48. Miyazaki I, Cheung RK, Dosch HM: Viral interleukin-10 is critical for the induction of B cell growth transformation by Epstein-Barr virus. J Exp Med 178:439, 1993
49. Tosato G, Tanner J, Jones KD, Revel M, Pike SE: Identification of interleukin-6 as an autocrine growth factor for Epstein-Barr virus-immortalized B cells. J Virol 64:3033, 1990
50. Baumann MA, Paul CC: Interleukin-5 is an autocrine growth factor for Epstein-Barr virus transformed B lymphocytes. Blood 79:1763, 1992
51. Paul NL, Ruddle NH: Lymphotoxin. Annu Rev Immunol 6:407, 1988
52. + malignant lymphomas. Crit Rev Oncog 4:191, 1993
53. + T lymphocytes correlates with down regulation of Th1 cytokine synthesis in helminth infection. J Immunol 147:2713, 1991
54. H2 switch is a critical step in the etiology of HIV infection. Immunol Today 14:107, 1993
55. Frisan T, Sjöberg J, Dolcetti R, Boiocchi M, De Re V, Carbone C, Brautbar C, Battat S, Biberfeld P, Eckman M, Öst A, Christensson B, Sundström C, Björkholm M, Pisa P, Masucci MG: Local suppression of Epstein-Barr virus (EBV)-specific cytotoxicity in biopsies of EBV-positive Hodgkin's disease. Blood 86:1493, 1995
56. Poppema S: The nature of the lymphocytes surrounding Reed-Sternberg cells in nodular lymphocyte predominance and in other types of Hodgkin's disease. Am J Pathol 135:351, 1989
57. Peuchmaur M, Emilie D, Crevon MC, Solal-Celigny P, Maillot MC, Legmaire G, Galanaud P: IL-2 mRNA expression in Tac-positive malignant lymphomas. Am J Pathol 136:383, 1990
58. Deacon EM, Pallesen G, Niedobitek G, Crocker J, Brooks L, Rickinson AB, Young LS: Epstein-Barr virus and Hodgkin's disease: Transcriptional analysis of virus latency in the malignant cells. J Exp Med 177:339, 1993
59. Levitskaya J, Coram M, Levitsky V, Imreh S, Steigerwald-Mullern PM, Klein G, Kurilla MG, Masucci MG: Inhibition of antigen processing by the internal repeat of the Epstein-Barr virus nuclear antigen-1. Nature 375:685, 1995
60. Chen HS, Kevan-Jah S, Suẍnzenich KO, Gresser FA, Müller-Lantzsch N: Expression of the Epstein-Barr virus latent membrane protein (LMP) in insect cells and detection of antibodies in human sera against this protein. Virology 190:106, 1992
61. Rochford R, Dawson CW, Mosier DE, Young LS: Epstein Barr virus latent proteins activated cytokine gene expression in epithelial cells, in: Epstein-Barr Virus and Associated Diseases. Cold Spring Harbor Meeting on Cancer Cells 1994 Book of Abstracts. Cold Spring Harbor, NY, Cold Spring Harbor Laboratory. 1994, p 70 (abstr)
62. Mosialos G, Birkenbach M, Yalamanchili R, VanArsdale T, Ware C, Kieff E: The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family. Cell 80:389, 1995
63. Rowe M, Peng-Pilon M, Huen DS, Hardy R, Croom-Carter D, Lundgren E, Rickinson AB: Upregulation of bcl-2 by the Epstein-Barr virus latent membrane protein LMP-1: A B-cell-specific response that is delayed relative to NF-κB activation and to induction of cell surface markers. J Virol 68:5602, 1994